CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - Nov '18 update

CEO Dr. Carl Schwartz and Richard Gabriel of Precision Therapeutics Inc. (NASDAQ: AIPT), join the show to talk in detail about the state of the recent merger, new technology for tumor and cancer testing, and plans for 2019. NASDAQ: AIPT # formerly Skyline Medical: SKLN # FDA-approved STREAMWAY® System # Helomics Corporation # Direct to drain system # automated # breast cancer # Cytopatch # D-chip #FDA cleared # Lung cancer # medical devices # Ovarian # patented # Precision Oncology # STREAMWAY® System # Tumor Genesis #  Tumor treatments # waste fluid management Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy